PRCT Q2 2025 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$79M+48.4% YoY

Gross Profit

$52M65.4% margin

Operating Income

-$22M-28.0% margin

Net Income

-$20M-24.7% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+14.5%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$18M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$513M

Total Liabilities

$127M

Stockholders' Equity

$386M

Cash & Equivalents

$303M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$79M	$53M	+48.4%
Gross Profit	$52M	$31M	+64.4%
Operating Income	-$22M	-$27M	+17.3%
Net Income	-$20M	-$26M	+23.6%

Geographic Segments

UNITED STATES

$70M88%

Outside the United States

$10M12%